Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein A Immunoadsorption vs IVIG in Guillain-Barre Syndrome
NCT05114941Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Changes in Hughes Functional Grading Scale scores at 4 weeks. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05114941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05114941.